May 13th 2024
Altuviiio was first granted approval by the FDA in February 2023.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea
Evidence of the relationship between probiotics and antibiotics is lacking.
Race, Income, & Insurance Type Remain Significant Barriers to Insulin Pump Use in Pediatric T1D
June 22nd 2022An analysis of the SEARCH for Youth in Diabetes describes historic and contemporary disparities in insulin pump use for pediatric type 1 diabetes based on racial/ethnic background, household income, and insurance type.
FreeStyle Libre 3 Gets FDA Clearance for Use in Patients 4 and Older
June 1st 2022The FreeStyle Libre 3 system, billed as the world's smallest, thinnest, and most accurate 14-day glucose sensor, received FDA clearance on May 31 and is expected to be available in participating pharmacies later this year.